As of 2025-05-28, the Gross Margin of Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811.SS) is 63.3%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2023-12-31 | 63.3% |
2022-12-31 | 67.1% |
2021-12-31 | 71.6% |
2020-12-31 | 73.6% |
2019-12-31 | 72.6% |
2018-12-31 | 64.1% |
2017-12-31 | 51.4% |
2016-12-31 | 50.3% |
2015-12-31 | 51.9% |
2014-12-31 | 49.3% |